ACQUIRER · M&A HISTORY
LabCorp: 5 Disclosed Acquisitions
Median deal value $237.6M. Total disclosed value: $1.42B.
LabCorp playbook
Disclosed deals
5
Median deal value
$237.6M
Sectors covered
2
Total disclosed value
$1.42B
Vertical focus
- Laboratory Services · 4 deals
- Other Healthcare · 1 deal
All 5 disclosed LabCorp acquisitions
- 2025 OPKO / BioReference Health (Clinical Diagnostics Business) · $192.5M
- 2024 OPKO / BioReference Clinical Diagnostics Business · $237.6M
- 2023 Enzo Biochem's Clinical Lab Business · $112.8M
- 2022 Ascension's Hospital Laboratories · $423.8M
- 2021 Personal Genome Diagnostics · $455.0M
LabCorp an active buyer in your vertical?
If LabCorp or a similar buyer is acquiring in your space, know your number before they call. Get an M&A-grade valuation range plus a sellability score, benchmarked against LabCorp-style transactions and 25,592 real M&A deals.
Value your business →Sourced from SEC filings, EDGAR 8-K/S-4, and verified press releases. Citation: ExitValue.ai. LabCorp M&A history. https://exitvalue.ai/buyer/labcorp